ACTIVE

SARDAPHARMA

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

22,2 k €

+173.5% YoY

Gross margin

178,4 k €

-10.1% YoY

Equity

237,7 k €

+10.3% YoY

What does SARDAPHARMA do?

SARDAPHARMA is a Private limited company incorporated in 2000. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Bruxelles.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0473.270.324

Incorporation

14/11/2000

Legal form

Private limited company

Registered office

Rue du Finistère 24
1000 Bruxelles · BruxellesSee on map

Contributed capital

18 592,01 €

Latest accounts

31/12/2024

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	178,4 k €	-10.1%	198,4 k €	+19.3%	166,2 k €	+16.2%	143 k €	+29.5%	110,4 k €	-23.2%	143,9 k €	-18.8%	177,2 k €	+67.1%	106,1 k €	-25.5%	142,3 k €	-3.4%	147,3 k €	+53.6%	95,9 k €	-20.5%	120,7 k €	+69.9%	71 k €	-2.0%	72,5 k €	-17.2%	87,6 k €	+2.3%	85,6 k €	+378%	-30,9 k €	-312%	14,5 k €	+3.4%	14,1 k €
EBITDA	123,8 k €	-13.0%	142,3 k €	-8.9%	156,3 k €	+15.4%	135,4 k €	+39.9%	96,8 k €	+48.5%	65,2 k €	-49.4%	128,9 k €	+113%	60,6 k €	-23.9%	79,6 k €	-5.0%	83,8 k €	+61.3%	51,9 k €	-31.7%	76,1 k €	+99.2%	38,2 k €	+13.7%	33,6 k €	-37.8%	54 k €	+2.4%	52,7 k €	+271%	-30,9 k €	-312%	14,5 k €	+3.4%	14,1 k €
Operating result	37,6 k €	-36.7%	59,3 k €	-19.1%	73,2 k €	-33.9%	110,9 k €	+54.3%	71,9 k €	+72.5%	41,7 k €	-61.2%	107,4 k €	+180%	38,4 k €	-33.2%	57,4 k €	-0.8%	57,9 k €	+152%	23 k €	-66.0%	67,6 k €	+367%	-25,3 k €	+15.2%	-29,9 k €	-191%	-10,3 k €	+38.4%	-16,7 k €	+45.9%	-30,9 k €	-312%	14,5 k €	+3.4%	14,1 k €
Net result	22,2 k €	+174%	8,1 k €	-33.7%	12,3 k €	-87.8%	100,7 k €	+213%	32,2 k €	+1075%	2,7 k €	-95.0%	54,4 k €	+834%	5,8 k €	-50.0%	11,7 k €	-8.7%	12,8 k €	+26.8%	10,1 k €	-81.1%	53,1 k €	+177%	-68,9 k €	-52.8%	-45,1 k €	-38.8%	-32,5 k €	+36.0%	-50,8 k €	-9.4%	-46,4 k €	-6244%	755,6 €	-72.5%	2,7 k €
Balance sheet
Equity	237,7 k €	+10.3%	215,4 k €	+3.9%	207,3 k €	+6.3%	195 k €	+107%	94,3 k €	+51.8%	62,2 k €	+4.6%	59,4 k €	+1094%	5 k €	+684%	-852,3 €	+93.2%	-12,5 k €	+50.5%	-25,3 k €	+28.5%	-35,3 k €	+60.1%	-88,5 k €	-352%	-19,6 k €	-177%	25,5 k €	-50.8%	51,9 k €	-49.5%	102,7 k €	-31.1%	149,1 k €	+0.5%	148,3 k €
Total assets	955,2 k €	-4.5%	1 M €	+5.6%	947,1 k €	-11.8%	1,1 M €	+16.7%	919,5 k €	-7.0%	988,9 k €	-6.5%	1,1 M €	-4.3%	1,1 M €	+12.9%	978,5 k €	-8.1%	1,1 M €	-0.3%	1,1 M €	+104%	524,3 k €	-0.1%	524,8 k €	-10.1%	583,6 k €	-8.1%	635 k €	-7.2%	684,6 k €	+35.1%	506,9 k €	-1.1%	512,7 k €	-1.7%	521,8 k €
Cash	39,4 €	-99.2%	5 k €	-37.1%	7,9 k €	+72.4%	4,6 k €	-9.1%	5 k €	-79.2%	24,2 k €	-6.1%	25,8 k €	+213%	8,2 k €	+302%	2 k €	-78.1%	9,3 k €	-64.6%	26,4 k €	+1306%	1,9 k €	-95.1%	38,1 k €	+370%	8,1 k €	-22.2%	10,4 k €	+1922%	516 €	+66906%	0,8 €	-87.1%	6 €	-19.8%	7,4 €
Debts	717,5 k €	-8.6%	784,9 k €	+6.1%	739,8 k €	-15.8%	878,2 k €	+6.4%	825,1 k €	-11.0%	926,8 k €	-7.1%	998 k €	-9.2%	1,1 M €	+12.3%	979,4 k €	-9.1%	1,1 M €	-1.5%	1,1 M €	+95.5%	559,6 k €	-8.7%	613,2 k €	+1.7%	603,2 k €	-1.0%	609,5 k €	-3.7%	632,7 k €	+56.5%	404,2 k €	+11.2%	363,6 k €	-1.8%	370,3 k €
Other
Workforce	–		0,9 ETP		–		–		1,5 ETP	0.0%	1,5 ETP	0.0%	1,5 ETP		–		–		1,5 ETP	+50.0%	1,0 ETP	0.0%	1,0 ETP	+25.0%	0,8 ETP	0.0%	0,8 ETP	+33.3%	0,6 ETP	0.0%	0,6 ETP		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2023 · 1 active · 5 ended

Active mandates

Boubker TAMOURO

Director · since 01 janvier 2010

Active

Ended mandates

Boubker TAMOURO

Director · since 25 juillet 2012

Ended

Boubker TAMOURO

Manager · since 25 juillet 2012

Ended

ANNE DEROISY

Manager · since 07 novembre 2000

Ended

ANNE DEROISY

Manager

Ended

At this address

Other companies at this address

Company	CBE no.
PHARMA RUE NEUVE● Active	0704.609.285

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Micro model	Abridged model	Abridged model	Micro model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/11/2025	06/11/2024	20/11/2023	06/11/2022	28/09/2021	02/06/2021
General meeting	21/05/2025	15/05/2024	10/05/2023	11/05/2022	19/05/2021	20/05/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/12/2024	21/05/2025	14/11/2025	French	PDF
Abridged model	31/12/2023	15/05/2024	06/11/2024	French	PDF
Abridged model	31/12/2022	10/05/2023	20/11/2023	French	PDF
Micro model	31/12/2021	11/05/2022	06/11/2022	French	PDF
Abridged model	31/12/2020	19/05/2021	28/09/2021	French	PDF
Abridged model	31/12/2019	20/05/2020	02/06/2021	French	PDF
Abridged model	31/12/2018	15/05/2019	05/07/2019	French	PDF
Abridged model	31/12/2017	16/05/2018	31/08/2018	French	PDF
Abridged model	31/12/2016	17/05/2017	20/09/2017	French	PDF
Abridged model	31/12/2015	18/05/2016	11/08/2016	French	PDF
Abridged model	31/12/2014	20/05/2015	29/08/2015	French	PDF
Abridged model	31/12/2013	21/05/2014	22/09/2014	French	PDF
Abridged model	31/12/2012	15/05/2013	30/08/2013	French	PDF
Abridged model	31/12/2011	16/05/2012	28/09/2012	French	PDF
Abridged model	31/12/2010	18/05/2011	29/07/2011	French	PDF
Abridged model	31/12/2009	19/05/2010	30/08/2010	French	PDF
Abridged model	31/12/2008	20/05/2009	20/08/2009	French	PDF
Abridged model	31/12/2007	14/05/2008	27/08/2008	French	PDF
Abridged model	31/12/2006	16/05/2007	09/10/2007	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2023 · 1 active · 5 ended

Active mandates

Boubker TAMOURO

Director · since 01 janvier 2010

Active

Ended mandates

Boubker TAMOURO

Director · since 25 juillet 2012

Ended

Boubker TAMOURO

Manager · since 25 juillet 2012

Ended

ANNE DEROISY

Manager · since 07 novembre 2000

Ended

ANNE DEROISY

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates18/06/2024
MODIFICATION FORME JURIDIQUE - DEMISSIONS, NOMINATIONS
PDF
Mandates03/08/2012
DEMISSIONS, NOMINATIONS
PDF
Restructuring30/04/2009
DENOMINATION - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, ) - MODIFICATION FORME JURIDIQUE - RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
PDF
Restructuring24/02/2009
RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...) - DIVERS
PDF
Registered office06/11/2002
SIEGE SOCIAL
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 202422,2 k €↑
2023
Annual accounts 20238,1 k €↓
2022
Annual accounts 202212,3 k €↓
2021
Annual accounts 2021100,7 k €↑
2020
Annual accounts 202032,2 k €↑
2019
Annual accounts 20192,7 k €↓
2018
Annual accounts 201854,4 k €↑
2017
Annual accounts 20175,8 k €↓
2016
Annual accounts 201611,7 k €↓
2015
Annual accounts 201512,8 k €↑
2014
Annual accounts 201410,1 k €↓
2013
Annual accounts 201353,1 k €↑
2012
Annual accounts 2012-68,9 k €↓
2011
Annual accounts 2011-45,1 k €↓
2010
Annual accounts 2010-32,5 k €↑
2009
Annual accounts 2009-50,8 k €↓
2008
Annual accounts 2008-46,4 k €↓
2007
Annual accounts 2007755,6 €↓
2006
Annual accounts 20062,7 k €
14/11/2000
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

SARDAPHARMA

Overview

What does SARDAPHARMA do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline